ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Hematology Oncology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,314Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 327

$4.4M Total Retail Price of All Prescriptions

Rank: 1 out of 327

901 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 901 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

3% of this provider’s 901 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

1% of this provider’s 25,712 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

60% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$167 was the average price of a prescription from this provider, compared to $364 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
NEXIUM 1,918 1,868 10 1 8
AMLODIPINE BESYLATE 1,485 1,458 2 3
LIDODERM 942 942 3 26
CELEBREX 794 794 4 37
ATORVASTATIN CALCIUM 665 651 5 7
SIMVASTATIN 662 630 6 2
JANUVIA 591 579 7 32
CRESTOR 584 574 8 22
LEVOTHYROXINE SODIUM 556 530 9 9
LOVAZA 548 544 10 17
DIOVAN 538 525 11 24
ALENDRONATE SODIUM 519 513 12 19
CREON 493 489 13 50
ATENOLOL 491 491 14 18
OMEPRAZOLE 448 441 15 6
METFORMIN HCL 445 429 16 13
METOPROLOL SUCCINATE 416 403 17 21
ENALAPRIL MALEATE 414 403 18 31
DIOVAN HCT 396 393 19 44
TAMSULOSIN HCL 373 366 20 28
GLIMEPIRIDE 345 341 21 40
ZOLPIDEM TARTRATE 335 335 22 16
AZITHROMYCIN 306 293 23 51
ATELVIA 300 300 24 70
LOSARTAN POTASSIUM 283 267 25 30
VOLTAREN 266 262 26 79
AMOX TR-POTASSIUM CLAVULANATE 265 250 27 75
BONIVA 258 258 10 28 105
LIPITOR 256 256 29 35
TRICOR 230 230 30 111
ACTONEL 224 220 31 95
MELOXICAM 214 209 32 46
LOSARTAN-HYDROCHLOROTHIAZIDE 206 206 33 60
MOMETASONE FUROATE 205 201 34 89
METOPROLOL TARTRATE 199 189 35 15
BENICAR 194 187 36 53
SYNTHROID 188 181 37 48
EVISTA 184 184 38 34
CIPROFLOXACIN HCL 176 172 39 61
IBANDRONATE SODIUM 169 169 40 127
TRILIPIX 164 162 41 129
BYSTOLIC 159 155 42 46
GLYBURIDE-METFORMIN HCL 151 142 R 43 100
SINGULAIR 150 150 44 65
CLOPIDOGREL 149 148 45 51
BENICAR HCT 149 148 45 109
DONEPEZIL HCL 141 141 47 38
DEXILANT 141 136 47 59
ZOSTAVAX 138 127 49 138
PROLIA 137 135 50 87
CARVEDILOL 133 129 51 42
NIFEDIPINE ER 129 125 52 76
FUROSEMIDE 125 120 53 14
PLAVIX 121 121 54 39
CLOTRIMAZOLE-BETAMETHASONE 116 110 55 107
AZOR 103 103 56 164
WELCHOL 103 103 56 118
ONGLYZA 102 101 58 111
AMMONIUM LACTATE 102 101 58 92
EXFORGE 102 101 58 167
PANTOPRAZOLE SODIUM 96 90 61 74
AMLODIPINE BESYLATE-BENAZEPRIL 96 96 61 95
PRAVASTATIN SODIUM 92 89 63 81
ZOMETA 87 86 10 64 84
JANUMET 79 78 65 106
ZENPEP 79 79 65 183
LANSOPRAZOLE 79 77 65 183
PRADAXA 78 78 68 141
EXEMESTANE 71 71 69 41
LEVOFLOXACIN 70 66 70 145
RECLAST 69 68 10 71 190
PROCTOZONE-HC 65 65 72 145
HYDROCHLOROTHIAZIDE 64 64 73 20
LYRICA 64 64 73 145
RAMIPRIL 63 63 75 142
RANITIDINE HCL 63 63 75 45
DILTIAZEM 24HR CD 62 62 77 140
AVODART 62 62 77 138
ESCITALOPRAM OXALATE 59 59 79 135
METFORMIN HCL ER 59 55 79 72
ONDANSETRON HCL 59 53 79 33
GLIPIZIDE XL 59 59 79 151
IBUPROFEN 59 57 79 119
LOVASTATIN 57 46 84 77
OXYCODONE-ACETAMINOPHEN 57 55 S2 84 92
FLECTOR 55 52 86 209
ACETAMINOPHEN-CODEINE 55 54 S3 86 157
MONTELUKAST SODIUM 53 53 88 148
DIGOXIN 51 51 89 126
CLONIDINE HCL 51 51 89 97
ANASTROZOLE 51 47 89 1
WARFARIN SODIUM 51 51 89 5
TARCEVA 50 50 93 55
LISINOPRIL 50 49 93 12
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 13, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.